SCHEMBL29567189

SCHEMBL29567189

COc1c(Oc2ccccc2C)nc(NS(=O)(=O)c2cnn(C)c2)nc1-c1ccccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 5/20 0.42
▸ HTR7 P34969 5/20 0.42
▸ DRD2 P14416 2/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ THRB P10828 2/20 0.35
▸ HIF1A Q16665 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ SLC22A12 Q96S37 1/20 0.34
▸ IGF1R P08069 1/20 0.34
▸ GHSR Q92847 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ PDGFRB P09619 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309396 1.00 HTR1A (0.42) HTR1AHTR7DRD2HTR6SMN1; SMN2
SCHEMBL29566871 0.92 HTR1A (0.39) HTR1AHTR7SMN1; SMN2TSHRHIF1A
SCHEMBL24309384 0.92 HTR1A (0.39) HTR1AHTR7SMN1; SMN2TSHRHIF1A
SCHEMBL24309852 0.91 HTR1A (0.46) HTR1AHTR7DRD2HTR6SMN1; SMN2
SCHEMBL29566476 0.91 HTR1A (0.46) HTR1AHTR7DRD2HTR6SMN1; SMN2
SCHEMBL24309827 0.90 HTR1A (0.43) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL29566900 0.90 HTR1A (0.43) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL29566758 0.90 HTR1A (0.40) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL24310674 0.90 HTR1A (0.40) HTR1AHTR7DRD2HTR6TSHR
SCHEMBL24310178 0.89 HTR1A (0.42) HTR1AHTR7DRD2HTR6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback